Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Releases WADAs 2026 Prohibited List is now in force The World Anti-Doping Agency (WADA) wishes to remind stakeholders that the 2026 List of Prohibited Substances and Methods (List) and the 2026 Monitoring Program are now in force as of today (1 January 2026)
Efficacy and safety of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a meta-analysis of randomized controlled trials for 1 to 2 years
GST pull-down was mixed with cell lysates from HEK293T cells, washed, and immunoblotted for NMHC-IIA and GST
We love hearing from you and learning about your experiences
(Princeton, NJ: Palatin Technologies) (2025)
Against this backdrop, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), first used for type 2 diabetes, have emerged as potent weight-loss agents with possible anti-inflammatory actions, making them attractive candidates in HS care
US$ 28.16
US$ 21.74
US$ 25.96
US$ 28.49
US$ 27.64
US$ 22.27
US$ 25.87
US$ 28.00
US$ 27.98
